Arineta Announces SpotLight Duo, a Breakthrough Cardiovascular CT Scanner
3 min read
Arineta announces SpotLight Duo
Arineta, a leading provider of medical imaging solutions, has announced the launch of SpotLight Duo, the first dedicated cardiovascular and thoracic CT scanner designed to provide comprehensive clinical information for diagnosis and therapy planning. SpotLight Duo is optimized for imaging the entire heart and cardiovascular system with 140 mm coverage at a rotation speed of 0.24 sec per rotation.
SpotLight Duo incorporates a number of innovative features that make it ideal for cardiovascular imaging, including:
- One-beat, high-definition, motion-free coronary images at any heart rate: SpotLight Duo uses a combination of intelligent motion correction and fast rotation speed to produce high-quality images of the heart and coronary arteries without the need for breath-holding or heart rate medication.
- Comprehensive cardiovascular imaging capabilities: SpotLight Duo can image the entire heart and cardiovascular system, including the coronary arteries, chambers, valves, and aorta. It can also be used to image the thoracic spine and lungs.
- Advanced imaging algorithms: SpotLight Duo features a number of advanced imaging algorithms that help to improve image quality and reduce artifacts. These algorithms include metal artifact reduction, deep learning-based image reconstruction, and image denoising.
SpotLight Duo is expected to have a significant impact on the diagnosis and treatment of cardiovascular disease. By providing high-quality, motion-free images of the heart and coronary arteries at any heart rate, SpotLight Duo can help clinicians to detect disease earlier and more accurately. Additionally, SpotLight Duo’s comprehensive imaging capabilities can help clinicians to better plan and guide cardiovascular interventions.
Arineta SpotLight Duo: A Breakthrough for Cardiovascular Imaging in the USA
The introduction of Arineta SpotLight Duo is a major breakthrough for cardiovascular imaging in the USA. SpotLight Duo’s unique combination of features, including its one-beat imaging capabilities, comprehensive cardiovascular imaging capabilities, and advanced imaging algorithms, make it ideal for the diagnosis and treatment of cardiovascular disease.
SpotLight Duo is expected to have a significant impact on the lives of patients with cardiovascular disease. By providing high-quality, motion-free images of the heart and coronary arteries at any heart rate, SpotLight Duo can help clinicians to detect disease earlier and more accurately. Additionally, SpotLight Duo’s comprehensive imaging capabilities can help clinicians to better plan and guide cardiovascular interventions.
How Arineta SpotLight Duo Can Benefit Patients in the USA
Arineta SpotLight Duo can benefit patients in the USA in a number of ways, including:
- Earlier and more accurate diagnosis of cardiovascular disease: SpotLight Duo’s one-beat imaging capabilities and advanced imaging algorithms can help clinicians to detect cardiovascular disease earlier and more accurately than traditional CT scanners. This can lead to earlier treatment and better outcomes for patients.
- Improved planning and guidance of cardiovascular interventions: SpotLight Duo’s comprehensive imaging capabilities can help clinicians to better plan and guide cardiovascular interventions, such as angioplasty and stenting. This can lead to shorter and more successful procedures for patients.
- Reduced need for invasive procedures: SpotLight Duo’s non-invasive imaging capabilities can help to reduce the need for invasive procedures, such as cardiac catheterization. This can lead to shorter hospital stays and faster recovery times for patients.
Overall, Arineta SpotLight Duo is a breakthrough cardiovascular CT scanner that has the potential to improve the lives of patients with cardiovascular disease in the USA.
